William Makis: Ivermectin and Fenbendazole in Pancreatic Cancer
William Makis, Nuclear Medicine Radiologist at Cross Cancer Institute, shared a post on X:
“NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial – 57 year old California man with Stage 2 Pancreatic Cancer has incredible response to 4 months of therapy
Pancreatic Cancer is not only treatable…it’s curable, but they don’t want you to know that!
57 year old California man with Stage 2 Pancreatic Cancer
We started:
Ivermectin 1.5mg/kg/day
Fenbendazole 1500mg/day
CBD Oil 100mg/day
Results after 4 months:
CA19-9: 2244 to 108
Pancreatic Mass 3.6×2.5cm to 1.6×2.5cm = 80% tumor volume shrinkage
Imagine what these results will look like 6 months, 8 months, 12 months after starting repurposed drugs.
I run the world’s largest Ivermectin Cancer Clinic.
We are the cutting edge of Cancer Treatment and Big Pharma is in a state of unmitigated panic.
Ivermectin, Fenbendazole, Mebendazole are the most successful repurposed drugs in recent history and will revolutionize medicine.
We’re already doing it every day.
Article Link in photo to avoid shadowban, just re-type the URL in the first photo at the top, into your browser to access.”
Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, shared this post on X, adding:
“4.1K likes and 169K views on this post…which fails to mention the patient was also receiving standard of care 1st line “big pharma” FOLFIRINOX chemotherapy (info buried in screenshotted email).”
More posts featuring Nina Niu Sanford on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023